Outcome of Treating Bladder Cancer in Sohag University Hospital

Outcome of Treating Urinary Bladder Cancer in Sohag University Hospital Between 2016 to 2020

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05082818

Enrollment

168

Registered

2021-10-19

Start date

2021-10-30

Completion date

2022-05-30

Last updated

2022-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer

Brief summary

Retrospective study of outcome of urinary bladder cancer treated in Sohag University hospital in the past 5 years from 2016 to 2020

Detailed description

This study asses the risk factors, prognosis,disease free survival and overall survive rate of treating urinary badder cancer

Interventions

COMBINATION_PRODUCTChemotherapy, Radiotherapy and surgery

Trans urethral resection of the tumour or radical cystectomy

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Inclusion criteria

* all stages and grades of urinary bladder cancer Any histological types of urinary bladder cancer

Exclusion criteria

* presence of other malignancies

Design outcomes

Primary

Measure	Time frame	Description
Disease free survival	2 weeks after treatment to the time of relapse	Time from the end of treatment to the date of first relapse

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026